Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women.

Ravizza M, Martinelli P, Bucceri A, Fiore S, Alberico S, Tamburrini E, Tibaldi C, Guaraldi G, Anzidei G, Maccabruni A, Crisalli MP, Floridia M; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy.

J Infect Dis. 2007 Mar 15;195(6):913-4; author reply 916-7. No abstract available.

PMID:
17299723
2.

Protease inhibitor-associated increased risk of preterm delivery is an immunological complication of therapy.

Fiore S, Ferrazzi E, Newell ML, Trabattoni D, Clerici M.

J Infect Dis. 2007 Mar 15;195(6):914-6; author reply 916-7. No abstract available.

PMID:
17299724
3.

Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?

Cotter AM, Garcia AG, Duthely ML, Luke B, O'Sullivan MJ.

J Infect Dis. 2006 May 1;193(9):1195-201. Epub 2006 Mar 28.

PMID:
16586354
4.

Protease inhibitor use during pregnancy: is there an obstetrical risk?

Tuomala RE, Yawetz S.

J Infect Dis. 2006 May 1;193(9):1191-4. Epub 2006 Apr 3. No abstract available.

PMID:
16586353
5.

Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003.

Martí C, Peña JM, Bates I, Madero R, de José I, Pallardo LF, Arribas JR, Gonzalez-Garcia J, Gonzalez A, Vazquez JJ.

Acta Obstet Gynecol Scand. 2007;86(4):409-15.

PMID:
17486461
6.

Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.

Schulte J, Dominguez K, Sukalac T, Bohannon B, Fowler MG; Pediatric Spectrum of HIV Disease Consortium.

Pediatrics. 2007 Apr;119(4):e900-6. Epub 2007 Mar 12.

PMID:
17353299
7.

Efficacy of low-dose boosted saquinavir once daily plus nucleoside reverse transcriptase inhibitors in pregnant HIV-1-infected women with a therapeutic drug monitoring strategy.

Lopez-Cortes LF, Ruiz-Valderas R, Rivero A, Camacho A, Marquez-Solero M, Santos J, García-Lazaro M, Viciana P, Rodriguez-Baños J, Ocampo A.

Ther Drug Monit. 2007 Apr;29(2):171-6.

PMID:
17417070
8.

Protease inhibitor treatment of HIV-1-infected women may protect against extreme prematurity and very low birth weight.

Beckerman KP.

J Infect Dis. 2007 Oct 15;196(8):1270-1; author reply 1271. No abstract available.

PMID:
17955447
9.

Antiretroviral medications during pregnancy for therapy or prophylaxis.

Stek AM.

Curr HIV/AIDS Rep. 2009 May;6(2):68-76. Review.

PMID:
19358777
10.

Predictors of stillbirth in sub-saharan Africa.

Chi BH, Wang L, Read JS, Taha TE, Sinkala M, Brown ER, Valentine M, Martinson F, Goldenberg RL.

Obstet Gynecol. 2007 Nov;110(5):989-97.

PMID:
17978109
11.

Endogenous interferon-alpha level is increased in hepatitis C virus (HCV)-positive pregnant women.

Paternoster DM, Belligoli A, Ngaradoumbe NK, Visentin S, Franco R, Fagiuoli S, Boldrin C, Palù G, Baldo V, Floreani A.

J Clin Gastroenterol. 2008 Feb;42(2):204-7. doi: 10.1097/01.mcg.0000247991.81591.2e.

PMID:
18209593
12.

Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.

Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.

AIDS. 2008 Sep 12;22(14):1815-20. doi: 10.1097/QAD.0b013e32830b8ab9.

PMID:
18753864
13.

The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery.

Boer K, Nellen JF, Patel D, Timmermans S, Tempelman C, Wibaut M, Sluman MA, van der Ende ME, Godfried MH.

BJOG. 2007 Feb;114(2):148-55.

14.

[Hepatitis C virus infection and pregnancy].

Bruguera M.

Gastroenterol Hepatol. 2000 Dec;23(10):480-2. Review. Spanish. No abstract available.

PMID:
11149224
15.

Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.

Read JS, Cahn P, Losso M, Pinto J, Joao E, Duarte G, Cardoso E, Freimanis-Hance L, Stoszek SK; NISDI Perinatal Study Group.

Obstet Gynecol. 2007 Jun;109(6):1358-67.

PMID:
17540808
16.

Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis.

Polis CB, Shah SN, Johnson KE, Gupta A.

Clin Infect Dis. 2007 Apr 15;44(8):1123-31. Epub 2007 Mar 7.

PMID:
17366462
17.

Risk factors of preterm delivery in HIV-infected pregnant women receiving zidovudine for the prevention of perinatal HIV.

Traisathit P, Mary JY, Le Coeur S, Thantanarat S, Jungpichanvanich S, Pornkitprasarn W, Gomutbutra V, Matanasarawut W, Wannapira W, Lallemant M.

J Obstet Gynaecol Res. 2009 Apr;35(2):225-33.

PMID:
19708170
18.

Update on antiretroviral therapy.

Riordan A, Bugembe T.

Arch Dis Child. 2009 Jan;94(1):70-4. doi: 10.1136/adc.2007.128744. Epub 2008 Oct 6. Review.

PMID:
18838416
19.

Antiretroviral therapy with a twice-daily regimen containing 400 milligrams of indinavir and 100 milligrams of ritonavir in human immunodeficiency virus type 1-infected women during pregnancy.

Ghosn J, De Montgolfier I, Cornélie C, Dominguez S, Pérot C, Peytavin G, Marcelin AG, Pauchard M, Ouagari Z, Bonmarchand M, Agher R, Calvez V, Bricaire F, Dommergues M, Katlama C, Tubiana R.

Antimicrob Agents Chemother. 2008 Apr;52(4):1542-4. doi: 10.1128/AAC.01301-07. Epub 2008 Feb 4.

20.

Prevention of mother-to-child HIV transmission using 3-drug combination antiretroviral treatment: observational cohort in clinical practice setting in India.

Patel AK, Patel KK, Sharma R, Ranjan RR, Shukla RK, Patel JA.

J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):231-3. doi: 10.1097/QAI.0b013e318189ab4e. No abstract available.

PMID:
19155769

Supplemental Content

Support Center